Nasdaq: MDWD

MediWound Ltd. (MDWD)

MediWound Ltd. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker MDWD. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
MDWD
Exchange
Nasdaq
SEC CIK
1593984
Official filings
SEC EDGAR

Research MDWD

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is MediWound Ltd.'s stock ticker?

MediWound Ltd. trades under the ticker symbol MDWD on Nasdaq. Its SEC Central Index Key (CIK) is 1593984.

Where can I read MediWound Ltd.'s SEC filings?

The MDWD SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports MediWound Ltd. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze MDWD's financial statements?

The MDWD Financials page shows MediWound Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does MDWD compare with its peers and the market?

The MDWD Peer Comparison page lines MediWound Ltd. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.